GoalTracker: Comparing Self-Monitoring Strategies for Weight Loss

April 24, 2018 updated by: Duke University

GoalTracker: Comparing Self-Monitoring Strategies for Weight Loss: Does Developing Mastery Before Tracking Diet Enhance Engagement?

This study is a randomized controlled trial that compares 3 self-monitoring approaches for weight loss. GoalTracker is a standalone, technology-based intervention using a commercial smartphone app (MyFitnessPal) and email.

The investigators hypothesize that the group that delays diet tracking and receives additional intervention components (weekly personalized feedback, skills training, and action plans) will have greater weight loss at the end of the 12-week intervention and at 6-month followup, compared to (a) an intervention group that simultaneously tracks weight and diet for all 12 weeks and receives the same additional components, and (b) a control group that tracks only diet.

Study Overview

Detailed Description

This study will examine whether a digital health intervention (GoalTracker) can promote weight loss among adults who are overweight or obese. Engagement in self-monitoring often declines over time, which is then associated with suboptimal weight loss. Finding ways to improve self-monitoring engagement, particularly in the first month of treatment, is needed. Promoting mastery, self-efficacy, and self-regulatory skills may help with maintaining high engagement.

The investigators aim to enroll 105 participants. All groups are asked to self-monitor daily on their smartphone using the free commercial mobile application MyFitnessPal over the course of the 12-week intervention.

Specifically, the study aims to...

  1. Determine the effect of a Sequential self-monitoring intervention, compared to a Simultaneous self-monitoring intervention on weight change, caloric intake change, and proportion of individuals achieving 5% weight loss.
  2. Determine the effect of the Sequential self-monitoring intervention, compared to the Control, on the same variables.
  3. Compare self-monitoring engagement by intervention arm.
  4. Examine the relation between self-monitoring engagement and weight loss.
  5. Investigate theoretical mediators (self-efficacy, mastery, and self-regulation) on the relation between treatment arm and weight change.

Study Type

Interventional

Enrollment (Actual)

105

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27705
        • Duke University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ages 21-65 years old
  • Body Mass Index (BMI) 25-45 kg/m2
  • interested in losing weight through dietary change
  • current use of iPhone or Android smartphone
  • current use of email address
  • has daily access to a bathroom scale
  • no recent weight loss (≥10 lbs) in the past 6 months
  • able to read and write in English
  • able to attend 3 in-person evaluation visits at Duke University in Durham, North Carolina over a 3-month period

Exclusion Criteria:

  • current participation in another weight loss treatment
  • currently pregnant or planning to become pregnant within study period, or < 1 year post-partum
  • history of cardiovascular event, eating disorder, diabetes mellitus, hypothyroidism, cancer, end stage renal disease
  • current uncontrolled hypertension
  • use of the MyFitnessPal app to track food in the past 6 months
  • Former or planned bariatric surgery
  • current use of medication (e.g., lithium, steroids, anti-psychotics)
  • use of weight loss medication in past 6 months
  • profound cognitive, developmental, or psychiatric disorders or recent hospitalization in a psychiatric facility

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Sequential Intervention
  • in this Sequential eHealth intervention, participants are asked to self-monitor only their body weight for the first month, then for months 2 and 3 they will be asked to also self-monitor their diet
  • participants are asked to use the MyFitnessPal app for self-monitoring
  • given goal to lose 5% weight by end of intervention (3 months)
  • weekly personalized feedback via email
  • weekly skills training materials (behavioral modification lessons; tips on using different features of the app) via email
  • weekly action plans via email
- weigh daily for 3 months and track their weight using the MyFitnessPal mobile app
  • track their diet (food and drinks) daily using the MyFitnessPal mobile app
  • when they are asked to track diet will vary based on the arm
- these are additional evidence-based intervention components
Experimental: Simultaneous Intervention
  • in this Simultaneous eHealth intervention, participants are asked to self-monitor both their body weight and diet for 3 months
  • participants are asked to use the MyFitnessPal app for self-monitoring
  • given goal to lose 5% weight by end of intervention (3 months)
  • weekly personalized feedback via email
  • weekly skills training materials (behavioral modification lessons; tips on using different features of the app) via email
  • weekly action plans via email
- weigh daily for 3 months and track their weight using the MyFitnessPal mobile app
  • track their diet (food and drinks) daily using the MyFitnessPal mobile app
  • when they are asked to track diet will vary based on the arm
- these are additional evidence-based intervention components
Experimental: Control (diet-tracking only)
  • participants are asked to self-monitor their diet for 3 months
  • participants are asked to use the MyFitnessPal app for self-monitoring
  • given goal to lose 5% weight by end of intervention (3 months)
  • track their diet (food and drinks) daily using the MyFitnessPal mobile app
  • when they are asked to track diet will vary based on the arm

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Weight
Time Frame: Baseline, 1 month, 3 months
Weight will be collected in kilograms using a calibrated digital scale
Baseline, 1 month, 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of Individuals Achieving ≥ 5% Weight Loss
Time Frame: Baseline to 3 months
Weight will be collected in kilograms using a calibrated digital scale
Baseline to 3 months
Change in Caloric Intake
Time Frame: Baseline, 3 months
Caloric intake will will be assessed using the Automated Self-Administered 24-hour Dietary Intake Assessment (ASA24), an online dietary recall tool developed by the National Cancer Institute
Baseline, 3 months
Change in Weight at 6 Months
Time Frame: 6 months
At 6-months (i.e., 3 months post-intervention), self-reported weight will be collected
6 months
Self-Monitoring Engagement
Time Frame: Baseline to 1-month and 3 months
Frequency of self-monitoring weight and diet; Consistency of self-monitoring weight and diet
Baseline to 1-month and 3 months
Self-Efficacy
Time Frame: Baseline, 1 month, 3 months
Weight Efficacy Lifestyle Questionnaire (WEL) (20 items) will assess self-efficacy for eating. Separate surveys that were adapted will assess self-efficacy for self-monitoring of diet and weight.
Baseline, 1 month, 3 months
Mastery
Time Frame: Baseline, 1 month, 3 months
The Automaticity subscale of The Self-Report Habit Index (SRHI) will assess mastery of self-monitoring diet and weight (4 items each).
Baseline, 1 month, 3 months
Self-Regulation
Time Frame: Baseline, 1 month, 3 months
The Three Factor Eating Questionnaire-R18 (TFEQ-R18) (18 items) will assess self-regulation for controlled eating. Separate surveys that were adapted will assess self-regulation for self-monitoring of diet and weight.
Baseline, 1 month, 3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity
Time Frame: Baseline, 3 months
Paffenbarger Activity Questionnaire (7 items) will assess physical activity.
Baseline, 3 months
Sleep Quality
Time Frame: Baseline, 1 month, 3 months
Medical Outcomes Study (MOS) Sleep (12 items) will assess sleep quality.
Baseline, 1 month, 3 months
Perceived Stress
Time Frame: Baseline, 3 months
Perceived Stress Scale (10 items)
Baseline, 3 months
Depressive Symptoms
Time Frame: Baseline, 1 month, 3 months
Patient Health Questionnaire (PHQ-8) will assess depressive symptoms.
Baseline, 1 month, 3 months
Health-Related Quality of Life
Time Frame: Baseline, 1 month, 3 months
EuroQol-5 Dimension (EQ-5D) (5 items) will assess health-related quality of life.
Baseline, 1 month, 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Michele G Lanpher, MA, Duke University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 19, 2017

Primary Completion (Actual)

December 11, 2017

Study Completion (Actual)

March 2, 2018

Study Registration Dates

First Submitted

August 7, 2017

First Submitted That Met QC Criteria

August 16, 2017

First Posted (Actual)

August 21, 2017

Study Record Updates

Last Update Posted (Actual)

April 25, 2018

Last Update Submitted That Met QC Criteria

April 24, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This data set is initially being used for the principal investigator's (Michele Lanpher) doctoral dissertation.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on self-monitoring of body weight

Subscribe